← Evidence map

ArticleChemistry & biodiversity2026

Development of Benzothiophene-Bearing Bis-oxadiazole Derivatives for Potential Anticancer Targets: Evaluation of DFT, ADME-Tox, and In Silico Docking.

Nagaraju Madala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Development of Benzothiophene-Bearing Bis-oxadiazole Derivatives for Potential Anticancer Targets: Evaluation of DFT, ADME-Tox, and In Silico Docking. | OpenQuestion